mResvia – Newly Approved RSV mRNA Vaccine

mResvia – Newly Approved RSV mRNA Vaccine

The FDA announced approval of a new RSV mRNA vaccine on October 23, 2024. This vaccine was developed and tested in a collaborative effort between ModernaTX and Merck and is intended for administration to adults 60 years of age or older. The press release announcing...

Influenza Shots for the 2024 – 2025 Season

Below you will find a summary of the approved influenza shots for this coming season. We found no material changes to the culturing method used for any of the approved vaccines, all of them using embryonated chicken eggs, specific pathogen-free eggs, MDCK canine cell...